Find Academic Supervisors

Ole Nørregaard Jensen is a Professor in Biomedical Mass Spectrometry and Systems Biology at the Department of Biochemistry and Molecular Biology, University of Southern Denmark . His research integrates advanced mass spectrometry, proteomics, and bioinformatics to study chromatin biology, post-translational modifications, and cellular signaling networks. He is actively involved in major research initiatives funded by Novo Nordisk Foundation and Lundbeck Foundation. His research interests include Mass Spectrometry, Proteomics, Posttranslational Modification, Histone Biology, Chromatin Biology, Bioinformatics, Systems Biology, Lipidomics, and Protein Chemistry . He employs cutting-edge techniques such as tandem mass spectrometry and ion mobility spectrometry to analyze protein isomers and dynamic modifications. His work has significant implications for understanding gene regulation, DNA replication, and disease mechanisms. His recent publications demonstrate a strong trend in chromatin dynamics, epigenetics, and integrated omics approaches , combining proteomics with transcriptomics and lipidomics to unravel complex biological systems. His research spans from fundamental molecular mechanisms to translational applications in biomedicine and food science. He has been recognized with several prestigious awards: MCP Lectureship Award Juan Pablo Albar Proteomics Pioneer Award 2019 EliteForsk 2009 prize Knight Order of Dannebrog (Ridder af Dannebrogordenen) Jensen is deeply involved in academic service, including peer review for journals like Nature Communications and Molecular and Cellular Proteomics , organizing conferences, and supervising students. He teaches courses such as Biomedical Mass Spectrometry - Principles and Applications and coordinates the Computational Biomedicine international Master’s program. He leads multiple active research projects, including PLATO and INTEGRA, focusing on health data, imaging, and protein networks. He is a key member of a vibrant research environment in biomedical mass spectrometry at SDU, contributing to both national and international scientific collaborations. His lab is at the forefront of developing and applying novel mass spectrometry methodologies for systems biology.

• Mass Spectrometry
• Proteomics
• Posttranslational Modification
• +9 more

Vijay Tiwari is a Professor in the Department of Molecular Medicine at the University of Southern Denmark (SDU), where he leads research in genome biology and epigenetics. He is affiliated with the Genome Biology VIP initiative and the Danish Institute for Advanced Study (DIAS), highlighting his role in interdisciplinary and high-impact scientific inquiry. His research focuses on epigenetic regulation of gene expression, particularly in the context of cancer and neuroimmunological disorders. Key areas include transcription factor dynamics, locus control regions, promoter regulation, and the role of epigenetic mechanisms in metastasis and immune responses in the central nervous system. The recent publications demonstrate a strong trend in single-cell omics, cancer immunology, and neurodegenerative disease modeling. His work bridges molecular biology with clinical applications, particularly in understanding cancer progression and regenerative failure in ageing. Articles frequently appear in high-impact journals such as Nature Communications , Cancer Research , and Molecular Cancer . Vijay Tiwari’s scientific contributions have received significant media attention, with multiple press releases from SDU highlighting breakthroughs in cancer research, including discoveries that may halt cancer spread. His work has been covered by numerous news outlets, blogs, and social media platforms, indicating broad scientific and public impact. He has advised several early-career researchers, including Inayatullah M. and Dwivedi A.K., who appear as co-authors on multiple publications. While specific grants are not listed, his consistent output and institutional affiliations suggest active funding and collaboration networks across Europe and globally. He is associated with research teams focused on genome biology and epigenetic regulation, likely operating within collaborative labs at SDU that integrate molecular, computational, and clinical approaches to biomedical research.

• Epigenetics
• Transcription Regulation
• Cancer Biology
• +12 more

Birgitte Skar is an Associate Professor and Collection Manager for the Stone Age and Bronze Age at the Department of Archaeology and Cultural History, NTNU Science Museum. Her research focuses on Mesolithic and Neolithic adaptations, biomolecular studies, submerged landscapes, and cultural heritage protection. She leads the SCAPES project (2025-2028), funded by RCN FRIPRO, exploring social complexity through biomolecular data. Her work integrates archaeology with genetics and isotopic analysis, addressing topics such as migration patterns, dietary practices, and social stratification in prehistoric societies. Key contributions include studies on Scandinavian Neolithic pathogens, Viking Age genetic diversity, and Mesolithic mobility in Fennoscandia. She advises numerous master’s students and collaborates with institutions like the University of Bergen and the Swedish Museum of Natural History. Publications span high-impact journals like Nature and Cell , alongside museum exhibitions and policy-oriented reports on heritage management. Her research often bridges natural sciences and humanities, emphasizing interdisciplinary approaches to understanding human-environment interactions.

• Archaeology
• Mesolithic Studies
• Biomolecular Analysis
• +4 more

Professor Alexander Breeze is a Chair in the School of Medicine at the University of Leeds, affiliated with the Multidisciplinary Cardiovascular Research Centre. His research focuses on structural biology, drug design, and molecular mechanisms of disease, particularly involving protein-protein interactions and NMR spectroscopy. Key areas include RAS oncogene inhibition, fibroblast growth factor receptors (FGFRs), and amyloid aggregation modulation. Education Background: Details of formal education not explicitly provided in the text, but extensive career history in structural biology and medicinal chemistry suggests advanced degrees in relevant fields. Research Interests: Professor Breeze’s work spans cardiovascular research, cancer biology, and infectious diseases. He develops novel therapeutics targeting oncogenic signaling pathways (e.g., RAS, FGFR) and investigates mechanisms of protein misfolding in amyloid diseases. His lab employs fragment-based drug design, NMR spectroscopy, and computational methods to study protein dynamics and drug interactions. Publications Overview: His recent work highlights advancements in small-molecule inhibitors for RAS proteins, CRACR2A genetic associations with COVID-19 severity, and modulation of amyloid aggregation pathways. Research trends emphasize translational applications, bridging basic science and clinical targets like cancer and neurodegenerative diseases. Awards & Recognition: No specific awards mentioned in the provided text, though his sustained high-impact publications suggest recognition in the field. Grants & Advising: Leadership in multidisciplinary cardiovascular research and training of early-career researchers through collaborative projects. No explicit grant details provided in this dataset. Labs & Teams: Active in the Multidisciplinary Cardiovascular Research Centre, fostering cross-departmental collaborations in cardiovascular and structural biology research.

• Cardiovascular Research
• Structural Biology
• Drug Design
• +7 more

Paola Ayala is a Professor at the Faculty of Physics of the University of Vienna, specializing in the Electronic Properties of Materials . Her research focuses on nanomaterials, particularly carbon nanotubes, graphene, and carbyne, exploring their electronic, magnetic, and optical properties. She leads the Doctoral College Advanced Functional Materials (DCAFM) (2020–2025), fostering interdisciplinary training in nanotechnology. Key research areas include nitrogen doping of carbon nanotubes, magnetic coupling in nanoclusters, and sensor applications of nanocomposites. She has pioneered studies on confined carbyne synthesis and the environmental stability of 1D nanocarbons. Ayala’s work bridges theoretical modeling (e.g., DFT simulations) and experimental techniques like Raman spectroscopy and XPS analysis. Her 2017 Matilde Hidalgo Prize recognizes contributions to nanomaterials science. She actively promotes STEM equity, co-authoring reports on women in physics in Austria and Ecuador. Ayala has supervised over 97 publications since 2007, with recent emphasis on functional nanomaterials for energy, sensing, and biomedical applications. Notable projects include developing flexible formaldehyde sensors and investigating magnetic properties of iron nanoclusters. She collaborates globally, presenting at conferences like the 2024 UNIVIE NanoteC Symposium and the 2023 International Nanotechnology Congress.

• Carbon Nanotubes
• Graphene
• Nanomaterials
• +3 more

Joseph Cotruvo is a Professor of Chemistry at the Department of Chemistry, Pennsylvania State University. His research focuses on understanding metal selectivity in biological systems, particularly lanthanides and transition metals, with applications in biotechnology, environmental science, and disease mechanisms. He leads the Cotruvo Lab, which develops biochemical and chemical biology tools to study metal ion acquisition, trafficking, and utilization in bacteria and human pathogens. Education: Ph.D., Chemistry, Massachusetts Institute of Technology (2012); A.B., Chemistry, Princeton University (2006). Research interests include lanthanide-dependent enzymology, protein engineering for rare earth element separations, and transition metal roles in neurodegenerative diseases. The lab designs fluorescent sensors, genetically encodable tools, and protein-based systems for metal detection and recovery. Recent work emphasizes actinide/lanthanide speciation, biohydrometallurgy, and biomolecular mechanisms of metal ion transport. Notable achievements include the discovery of lanmodulin—a highly selective lanthanide-binding protein—and its application in rare earth element recovery. His lab pioneered protein-based approaches for high-purity rare earth separations and developed manganese(II) fluorescent sensors. Research also explores iron-responsive riboswitches and copper-regulated lipid metabolism. Awards: Faculty Scholar Medal (2025), Blavatnik Finalist (2024), Eli Lilly Award (2024), Sloan Fellowship (2021), DOE Early Career Award (2020). Grants: NSF CAREER Award, Charles E. Kaufman Foundation, Jane Coffin Childs Memorial Fund. Labs/Teams: Cotruvo Lab (Penn State); collaborations with National Synchrotron Light Source, Lawrence Livermore National Laboratory. Future work targets scalable rare earth recovery systems, actinide-biomolecule interactions, and transition metal roles in infectious diseases.

• Biochemistry
• Biophysics
• Catalysis
• +9 more

Dr. Kim O'Sullivan is a Senior Research Fellow and head of the Translational Kidney Therapies Group at the Centre for Inflammatory Diseases (CID), Monash Health Translational Precinct, affiliated with Monash University’s Faculty of Medicine, Nursing and Health Sciences. She holds a PhD in Immunology from Monash University and completed her undergraduate and Master’s studies in Anatomy and Structural Biology at the University of Otago, New Zealand. Her work is centered on developing novel therapies for autoimmune kidney diseases, particularly ANCA-associated vasculitis (AAV), glomerulonephritis, and lupus nephritis. Her research focuses on: Neutrophil Extracellular Traps (NETs) and their role in inflammation Gene therapy using adeno-associated viral vectors to deliver DNase I Therapeutic potential of bacterial exosomes Gut microbiome interactions, especially Muribaculaceae and SCFAs Immune tolerance and host defense preservation Her recent publications (2023–2024) reflect a strong trend in translational immunology, with emphasis on microbiome-immune crosstalk, novel biologics, and gene-based interventions. She has published in high-impact journals such as Frontiers in Immunology , International Journal of Molecular Sciences , and Journal of Immunology . Her scientific contributions have been recognized through several awards: Australian and New Zealand Society of Nephrology Young Investigator Award (Winner, 2016) ANZSN Basic Science Award (Finalist, 2020) Multiple ANZSN Travel Awards (2014, 2016, 2017) Kim O'Sullivan actively supervises Honours and PhD students and leads multiple research projects funded by NHMRC and MRFF. She serves on the ANZSN Scientific Programme and Awards Committee (SPARC), is a Review Editor for Frontiers in Immunology , and sits on the editorial boards of International Journal of Molecular Sciences and Journal of Integrated Medicine in Nephrology and Andrology . She is also a peer reviewer for top journals including Journal of Clinical Investigation and Kidney International . She leads the CID weekly seminar series and chaired the ImmuMON21 symposium. Her commitment to equity in STEM includes mentoring through BrainSTEM and past involvement in the ANZSN Equity, Diversity and Inclusion Committee.

• Immunology
• Autoimmune Diseases
• Kidney Disease
• +13 more

Prof. Dr. Andreas Pichlmair is an Associate Professor at the Technical University of Munich (TUM) since 2017, leading the Immunopathology of Viral Infections group within the TUM School of Medicine and Health . His research focuses on understanding virus-host interactions, particularly the innate immune response to viral pathogens. He earned his DVM (2004) from the University of Freiburg and PhD (2008) from Cancer Research UK, followed by postdoctoral work at the Center for Molecular Medicine in Vienna (2008-2011) and a Max Planck Free Floater Program (2011-2017). Research Interests : His lab investigates viral sensing mechanisms, antiviral immunity, and systems-level proteomic approaches to dissect host-pathogen dynamics. Key areas include RIG-I signaling, IFIT protein function, and novel cell death pathways like oxeiptosis. His work integrates mass spectrometry, functional genomics, and in vivo models to identify host factors critical for viral replication and immune evasion. Awards : Loefler Frosch Prize (2013) Pontecorvo Prize (2008) Golden Badge of Honor (2006) Lab Team : Includes PhD students (e.g., Valter Bergant, Yiqi Huang) and postdocs (e.g., Pietro Scaturro, Alexey Stukalov). The group collaborates extensively on SARS-CoV-2 research and antiviral drug discovery.

• Virology
• Immunology
• Molecular Biology
• +4 more

Kathie Therese Hodge is an Associate Professor at Cornell University's School of Integrative Plant Science, specializing in fungal systematics and plant/insect pathogens. She leads the Cornell Plant Pathology Herbarium (CUP), a globally significant biodiversity repository with 300,000+ specimens. Her research focuses on fungal biodiversity, mycotoxin production in food systems, and evolutionary relationships among fungi. She also serves as Associate Director of Teaching for the School. Education: Ph.D. (1998), M.S. (1993) from Cornell University; B.Sc. (1990) from University of Toronto. Teaching includes courses like 'Magical Mushrooms, Mischievous Molds' and field-based 'Mushrooms of Field and Forest,' reaching over 300 undergraduates annually. Research Interests: Fungal classification and evolution Pathogens impacting global food systems Biohybrid robotics using fungal networks Public outreach on mycology Notable Achievements: 2024 Donald C. Burgett Distinguished Advisor Award Recipient of NSF-funded herbarium digitization projects Pioneered Paecilomyces niveus research linking fungal spoilage to patulin contamination Outreach: Leads New York State 'Peck' mushroom foray, maintains the Cornell Mushroom Blog and @cornellfungi Instagram, and advises on mushroom poisoning emergencies.

• Fungal Systematics
• Fungal Pathogens of Plants and Insects
• Fungal Biodiversity
• +3 more

Matthew L. Boulton is a Pearl L. Kendrick Collegiate Professor of Global Public Health and Professor of Epidemiology at the University of Michigan School of Public Health (SPH). He serves as Senior Associate Dean for Global Public Health and Director of the Office of Global Public Health. He also holds roles as Editor-in-Chief of the American Journal of Preventive Medicine , Director of the Preventive Medicine Residency, and Associate Director of the Behavioral Health Workforce Research Center. Previously, he was Associate Dean for Practice (2004–2010) and founded the Office of Public Health Practice. Before joining U-M, he worked as a state epidemiologist and medical director in public health departments. Education: MD (University of Nevada, 1987), MPH (University of Michigan, 1991), BS in Plant Biology and Zoology (University of Nevada, 1980). Research Interests: Global public health, infectious disease epidemiology, childhood vaccinations, vaccine equity, and health workforce studies. His research focuses on vaccine preventable diseases, immunization systems, and global health equity. Notable projects include the Minority Health & Health Disparities International Research Training Program and collaborations with the CDC and Tianjin CDC in China. Awards: Over 40 awards, including the Faculty Excellence in Teaching Award, Alumni of the Year, and John H. Romani Award for public health leadership.

• Global Public Health
• Infectious Disease Epidemiology
• Childhood Vaccinations
• +3 more

Dr. Martin F. Semmelhack is a Professor of Chemistry at Princeton University, leading the Semmelhack Lab. His research focuses on designing small molecules to modulate biological processes, particularly bacterial quorum sensing mechanisms in pathogens like Vibrio cholerae and Pseudomonas aeruginosa. His work aims to develop anti-infective drugs by targeting cell communication pathways. Key research areas include synthetic organic chemistry, chemical biology, and bacterial signaling pathways. Notable contributions include the discovery of autoinducers CAI-1 and AI-2, and the development of quorum sensing agonists/antagonists. Collaborations with microbiologists and neuroscientists expand applications into biofilm inhibition and neurotransmitter release technologies. His honors include the Arthur C. Cope Scholar Award (2014), John Simon Guggenheim Fellowship (1978–1979), and Camille and Henry Dreyfuss Teacher-Scholar Grant (1972–1977). Research combines chemical synthesis with biological testing to bridge molecular design and therapeutic potential. Advising and grant activities include funding from the National Institutes of Health and National Science Foundation, supporting interdisciplinary projects. The Semmelhack Lab is located in the Frick Laboratory, Princeton University.

• Chemical Biology
• Quorum Sensing
• Catalysis/Synthesis
• +7 more

Cameron A. Myhrvold is an Assistant Professor of Molecular Biology at Princeton University, leading the Myhrvold Lab. His research focuses on CRISPR-based technologies to study viral and host RNA, with applications in detecting and combating RNA viruses like SARS-CoV-2. He specializes in developing Cas13-based tools for multiplexed nucleic acid detection, host-pathogen interaction analysis, and RNA perturbation. Education: A.B. in Molecular Biology from Princeton University (undergraduate), Ph.D. in Systems Biology from Harvard University. His postdoctoral work at Harvard involved pioneering CRISPR-Cas13 technologies, leading to innovations like CARMEN, CARVER, and SHINE. Research interests include: CRISPR-based RNA editing, quantitative nucleic acid detection, systems biology of viral infections, and translating technologies for global health. His lab emphasizes deploying diagnostics in resource-limited settings and studying viral dynamics across diverse tissues and infection conditions. Notable achievements: Named NEBEC Emerging Young Investigator. His work has advanced field-deployable viral diagnostics and multiplexed RNA analysis tools. Collaborates with institutions like the Broad Institute and the CDC on pandemic response initiatives. Current projects include developing quantitative CARMEN variants for gene expression analysis, high-throughput screening of Cas13-virus interactions, and applying CRISPR tools to study influenza and SARS-CoV-2 in animal models.

• CRISPR-based technologies
• Viral RNA studies
• Host-pathogen interactions
• +7 more

Danika Hill is a Senior Research Fellow in the Department of Immunology and Pathology at Monash University. Her research focuses on understanding cellular and molecular mechanisms of immune responses to vaccination and infection, particularly in T follicular helper cells and germinal center biology. She investigates pathogens such as Group A Streptococcus, malaria, and influenza using advanced techniques like high-parameter flow cytometry and single-cell sequencing. Education: BSc in Biomedical Science (University of Adelaide), PhD (Walter and Eliza Hall Institute). Postdoctoral training at the Babraham Institute (Cambridge) before joining Monash in 2020. Funded by NHMRC CJ Martin Fellowship and Michelson Prize. Recognized as a 'Rising Star in Immunology' by the Norwegian Society for Immunology. Research Interests T follicular helper cell dynamics and germinal center regulation Long-lived antibody responses and vaccine design Age-related immune dysfunction Immune responses to infectious diseases Awards Michelson Prize (2020) Margaret Baird Women in Immunology Award (2022) NHMRC CJ Martin Fellowship (2018) Best Oral presentation awards (2020, 2022) Grants & Projects "Discovering molecular signatures of human T follicular helper cells and antibody-producing B cells" (NHMRC, 2018–2023) "Structure-based antigen design for mRNA vaccines" (2023–2025) Labs/Teams: Leads her own lab at Monash, collaborating internationally on vaccine efficacy and immune mechanisms.

• Immunology
• Vaccine Development
• Cellular and Molecular Mechanisms of Immunity
• +5 more

Gordon Ramage is a Professor of Infection Prevention and Control at Glasgow Caledonian University's School of Health & Life Sciences. He holds a B.Sc. (Hons) in Medical Microbiology from Edinburgh University (1996) and a Ph.D. in Prosthetic Joint Infections from Queen's University Belfast (1999). After postdoctoral work in North America (2000-2003), he held academic positions at GCU and University of Glasgow Dental School before returning to GCU in October 2023. Education: B.Sc. (1996), Ph.D. (1999) Academic Roles: Lecturer (2004), Senior Lecturer (2007), Professor (2012) His research focuses on biofilm infections , particularly Candida auris persistence in hospitals, antifungal resistance , and biofilm disruption strategies like phage therapy. Recent projects address dry surface biofilms, wound healing applications, and oral microbiome analysis. Research trends show sustained activity in biofilm pathogenesis (2001-2025) with 228 total outputs, including high-impact work on C. albicans (38%) and aspergillus (75%). Scientific Recognition: FRCPath (Royal College of Pathologists) FECMM (European Confederation of Medical Mycology) Chair, ESCMID Biofilms Study Group (2021-2025) Active in supervising students and leading grants like BIDOPT (Phage Therapy) and Assembly of Practical Evidence Base for C. auris . Affiliated with GCU's ReaCH group and SHIP research cluster.

• Infection Prevention and Control
• Medical Microbiology
• Biofilm Research
• +3 more

Morten Nielsen is a Professor at the Department of Health Technology, Technical University of Denmark, specializing in Bioinformatics with a focus on Immunoinformatics and Machine Learning . His research develops pattern recognition algorithms for immune system characterization and protein structure analysis, contributing to vaccine design against infectious diseases like HIV and tuberculosis. Professor since 2008 Director of Algorithm in Bioinformatics course (27623) Active in 8 current and 27 completed research projects Research spans epitope prediction , T-cell receptor modeling , and genomic variation analysis of pathogens. Recent work (2024) includes cancer neo-epitope immunogenicity studies, B-cell epitope prediction tools (DiscoTope-3.0), and TCR specificity modeling using machine learning. Current projects involve deep immune receptor modeling , personalized neoantigen screening , and autoimmunity pattern identification , with students including L. Machado, B. Scapolo, S. N. Deleuran, G. Nos, and A. B. Saksager.

• Immunoinformatics
• Bioinformatics
• Machine Learning
• +6 more